Displaying 2081 - 2100 of 4528
Superior/Canexus, In the Matter of
The FTC filed an administrative complaint charging that the proposed $982 million merger of Canadian chemical suppliers Superior Plus Corp. and Canexus Corp. would violate the antitrust laws by significantly reducing competition in the North American market for sodium chlorate – a commodity chemical used to bleach wood pulp that is then processed into paper, tissue, diaper liners, and other products. Superior and Canexus are two of the three major producers of sodium chlorate in North America. If the merger takes place, the new company and rival AkzoNobel will control approximately 80 percent of the total sodium chlorate production capacity in North America. By combining more than half of all North American sodium chlorate production capacity in the merged Superior and Canexus, the acquisition is likely to lead to anticompetitive reductions in output and higher prices, the complaint alleges. Additionally, by removing Canexus as an independent sodium chlorate producer, with its large scale and low-costs, the acquisition will also increase the likelihood of coordination in an already vulnerable market, according to the complaint. The FTC also authorized staff to seek a temporary restraining order and a preliminary injunction in federal court to prevent the parties from consummating the merger and to maintain the status quo pending the administrative proceeding. The FTC and the Canadian Competition Bureau collaborated in this investigation. On June 30, the parties abandoned their plans.
Federal Trade Commission (Bureau of Competition) and Department of Justice (Antitrust Division): Hart-Scott-Rodino Annual Report: Fiscal Year 2015: Section 7A of the Clayton Act, 15 U.S.C. 18A (The Hart-Scott-Rodino Antitrust Improvements Act of 1976)
FTC Approves Fiscal Year 2015 Hart Scott Rodino Premerger Notification Report
FTC Requires Teva to Divest Over 75 Generic Drugs to Settle Competition Concerns Related to its Acquisition of Allergan’s Generic Business
As a Condition of Acquiring Meda, FTC Requires Mylan to Divest Rights to Two Generic Drugs, One for Muscle Spasms and Stiffness, the other for Epilepsy
FTC Requests Public Comment on American Air Liquide Holdings, Inc.’s Application to Approve Divestiture of Assets to Aspen Air U.S. Corp.
FTC Staff Supports Department of Veterans Affairs Proposed Rule To Grant Full Practice Authority to Advanced Practice Registered Nurses
FTC Requires Ahold and Delhaize Group to Sell 81 Stores as a Condition of Merger
1607011 Informal Interpretation
1607010 Informal Interpretation
1607008 Informal Interpretation
FTC Approves Final Order Preserving Competition among Suppliers of Industrial Gases
1607005 Informal Interpretation
Officials from U.S. and Japan Participate in 35th Bilateral Meeting in Washington to Discuss Antitrust Enforcement
FTC Approves Final Order Settling Monopolization Charges Against Supplier of High-Performance Polymer for Medical Implants
1607004 Informal Interpretation
1607003 Informal Interpretation
Len Blavatnik, Care of Access Industries
Investor Len Blavatnik has agreed to pay $656,000 in civil penalties to resolve charges that he violated federal premerger reporting laws by failing to report voting shares that he acquired in a California technology start up called TangoMe, in August 2014.
Displaying 2081 - 2100 of 4528